ORIGINAL RESEARCH
Accepted on 11 Jun 2025
Senescence-associated signature based on immunotherapy response sequencing reveals PPIL3 as target for bladder cancer treatment and prognosis prediction
doi 10.3389/fimmu.2025.1613056
- 160 views
544
Total downloads
4,536
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
ORIGINAL RESEARCH
Accepted on 11 Jun 2025
REVIEW
Published on 04 Apr 2025
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: